Business Wire

Mary Kay Inspires Next Generation of Female STEAM Leaders at Youth Summit

Share

Mary Kay Inc., a global advocate for women’s empowerment and education, recently hosted a group of 25 young women from Dallas Independent School District’s Young Women’s Preparatory Network (YWPN) / Irma Lerma Rangel Young Women’s Leadership School for an educational, inspirational exploration of Women in STEAM. The events led up to the celebration of International Day of Women and Girls in Science on February 11.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230213005585/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Mary Kay Inc. welcomed students from the Irma Lerma Rangel Young Women’s Leadership School to R3 for a STEAM themed summit exploring being a woman in STEAM. (Photo: Mary Kay Inc.)

The high school-aged students spent the day at Mary Kay’s Richard R. Rogers Manufacturing / R&D Center (R3) in Lewisville, TX, where they toured the state-of-the-art facility and learned about the different aspects of STEAM-related manufacturing processes in a complex, global beauty company. Following the tour, students heard from a panel of female experts in their respective STEAM fields. The panel was comprised of experts in fields such as Upstream Innovation, Product Formulation, Information Technology, Product Research, Portfolio & Strategy Planning and Process Development. In the afternoon, students engaged in a mentoring lunch where they had the opportunity to discuss different career paths for women in STEAM, personal and professional aspirations, and how we can better encourage, prepare and bolster young women pursuing careers in STEAM fields.

“Mary Kay is committed to empowering and inspiring the next generation of women to pursue their passions—because the future is STEAM,” said Dr. Lucy Gildea, Chief Innovation Officer, Product and Science at Mary Kay. “Women are underrepresented in the STEAM workforce, but we can narrow that gap by providing critical early learning opportunities and exposure for young women to seek out and explore STEAM careers of interest.”

Young Women’s Preparatory Network is a nonprofit agency that partners with public school districts across the state of Texas to operate the largest network of all-girl, public, college preparatory schools in the nation. YWPN schools are located in struggling urban neighborhoods and have a proven track record of academic achievement, high school graduate and college acceptance rates. YWPN formed the first public/private partnership with the Dallas Independent School District, opening the Irma Lerma Rangel Young Women’s Leadership School in 2004.

“We are thrilled to have our young women participate in a day filled with meaningful connections to women in STEAM, and are grateful to Mary Kay for this opportunity,” said Lynn McBee, Chief Executive Officer, Young Women’s Preparatory Network. “These future leaders are bright, talented young women. To have exposure to other successful women in STEAM fields and see the impact they can make provides them that extra motivation to reach farther, achieve more, and hopefully, one day, change the world through STEAM.”

Mary Kay celebrates and encourages young women who are taking charge of their futures through leadership, innovation, and determination to excel in STEAM fields. Women make up only 28% of the workforce in science, technology, engineering and math. [1] By offering continued support to young women in STEAM fields, the company is continuing Mary Kay’s mission, which is to improve the lives of women everywhere.

[1] Sources
National Girls Collaborative Project (2022). The State of Girls and Women in Stem. https://ngcproject.org/resources/state-girls-and-women-stem

About Mary Kay Inc.

One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in 35 plus countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Mary Kay Inc. Global Communications
newsroom.marykay.com
+1.972.687.5332
media@mkcorp.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye